1 Amiodarone Market Overview 1.1 Product Overview and Scope of Amiodarone 1.2 Amiodarone Segment by Type 1.2.1 Global Amiodarone Sales Growth Rate Comparison by Type (2021-2027) 1.2.2 Tablet Amiodarone 1.2.3 Capsule Amiodarone 1.2.4 Injection Amiodarone 1.3 Amiodarone Segment by Application 1.3.1 Global Amiodarone Sales Comparison by Application: (2021-2027) 1.3.2 Cardiac Arrest 1.3.3 Ventricular Tachycardia 1.3.4 Atrial Fibrillation 1.3.5 Others 1.4 Global Amiodarone Market Size Estimates and Forecasts 1.4.1 Global Amiodarone Revenue 2016-2027 1.4.2 Global Amiodarone Sales 2016-2027 1.4.3 Amiodarone Market Size by Region: 2016 Versus 2021 Versus 2027 2 Amiodarone Market Competition by Manufacturers 2.1 Global Amiodarone Sales Market Share by Manufacturers (2016-2021) 2.2 Global Amiodarone Revenue Market Share by Manufacturers (2016-2021) 2.3 Global Amiodarone Average Price by Manufacturers (2016-2021) 2.4 Manufacturers Amiodarone Manufacturing Sites, Area Served, Product Type 2.5 Amiodarone Market Competitive Situation and Trends 2.5.1 Amiodarone Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest Amiodarone Players Market Share by Revenue 2.5.3 Global Amiodarone Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Amiodarone Retrospective Market Scenario by Region 3.1 Global Amiodarone Retrospective Market Scenario in Sales by Region: 2016-2021 3.2 Global Amiodarone Retrospective Market Scenario in Revenue by Region: 2016-2021 3.3 North America Amiodarone Market Facts & Figures by Country 3.3.1 North America Amiodarone Sales by Country 3.3.2 North America Amiodarone Revenue by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Amiodarone Market Facts & Figures by Country 3.4.1 Europe Amiodarone Sales by Country 3.4.2 Europe Amiodarone Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Amiodarone Market Facts & Figures by Region 3.5.1 Asia Pacific Amiodarone Sales by Region 3.5.2 Asia Pacific Amiodarone Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Amiodarone Market Facts & Figures by Country 3.6.1 Latin America Amiodarone Sales by Country 3.6.2 Latin America Amiodarone Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.7 Middle East and Africa Amiodarone Market Facts & Figures by Country 3.7.1 Middle East and Africa Amiodarone Sales by Country 3.7.2 Middle East and Africa Amiodarone Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global Amiodarone Historic Market Analysis by Type 4.1 Global Amiodarone Sales Market Share by Type (2016-2021) 4.2 Global Amiodarone Revenue Market Share by Type (2016-2021) 4.3 Global Amiodarone Price by Type (2016-2021) 5 Global Amiodarone Historic Market Analysis by Application 5.1 Global Amiodarone Sales Market Share by Application (2016-2021) 5.2 Global Amiodarone Revenue Market Share by Application (2016-2021) 5.3 Global Amiodarone Price by Application (2016-2021) 6 Key Companies Profiled 6.1 Sanofi 6.1.1 Sanofi Corporation Information 6.1.2 Sanofi Description and Business Overview 6.1.3 Sanofi Amiodarone Sales, Revenue and Gross Margin (2016-2021) 6.1.4 Sanofi Amiodarone Product Portfolio 6.1.5 Sanofi Recent Developments/Updates 6.2 Sawai Pharmaceutical 6.2.1 Sawai Pharmaceutical Corporation Information 6.2.2 Sawai Pharmaceutical Description and Business Overview 6.2.3 Sawai Pharmaceutical Amiodarone Sales, Revenue and Gross Margin (2016-2021) 6.2.4 Sawai Pharmaceutical Amiodarone Product Portfolio 6.2.5 Sawai Pharmaceutical Recent Developments/Updates 6.3 Wyeth Pharmaceuticals(Pfizer) 6.3.1 Wyeth Pharmaceuticals(Pfizer) Corporation Information 6.3.2 Wyeth Pharmaceuticals(Pfizer) Description and Business Overview 6.3.3 Wyeth Pharmaceuticals(Pfizer) Amiodarone Sales, Revenue and Gross Margin (2016-2021) 6.3.4 Wyeth Pharmaceuticals(Pfizer) Amiodarone Product Portfolio 6.3.5 Wyeth Pharmaceuticals(Pfizer) Recent Developments/Updates 6.4 Mylan Pharmaceuticals 6.4.1 Mylan Pharmaceuticals Corporation Information 6.4.2 Mylan Pharmaceuticals Description and Business Overview 6.4.3 Mylan Pharmaceuticals Amiodarone Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Mylan Pharmaceuticals Amiodarone Product Portfolio 6.4.5 Mylan Pharmaceuticals Recent Developments/Updates 6.5 Arrow Pharma Pty Ltd 6.5.1 Arrow Pharma Pty Ltd Corporation Information 6.5.2 Arrow Pharma Pty Ltd Description and Business Overview 6.5.3 Arrow Pharma Pty Ltd Amiodarone Sales, Revenue and Gross Margin (2016-2021) 6.5.4 Arrow Pharma Pty Ltd Amiodarone Product Portfolio 6.5.5 Arrow Pharma Pty Ltd Recent Developments/Updates 6.6 Roemmers 6.6.1 Roemmers Corporation Information 6.6.2 Roemmers Description and Business Overview 6.6.3 Roemmers Amiodarone Sales, Revenue and Gross Margin (2016-2021) 6.6.4 Roemmers Amiodarone Product Portfolio 6.6.5 Roemmers Recent Developments/Updates 6.7 Cipla Pharmaceutical 6.6.1 Cipla Pharmaceutical Corporation Information 6.6.2 Cipla Pharmaceutical Description and Business Overview 6.6.3 Cipla Pharmaceutical Amiodarone Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Cipla Pharmaceutical Amiodarone Product Portfolio 6.7.5 Cipla Pharmaceutical Recent Developments/Updates 6.8 Shanghai Pharmaceuticals 6.8.1 Shanghai Pharmaceuticals Corporation Information 6.8.2 Shanghai Pharmaceuticals Description and Business Overview 6.8.3 Shanghai Pharmaceuticals Amiodarone Sales, Revenue and Gross Margin (2016-2021) 6.8.4 Shanghai Pharmaceuticals Amiodarone Product Portfolio 6.8.5 Shanghai Pharmaceuticals Recent Developments/Updates 6.9 North China Pharmaceutical Company 6.9.1 North China Pharmaceutical Company Corporation Information 6.9.2 North China Pharmaceutical Company Description and Business Overview 6.9.3 North China Pharmaceutical Company Amiodarone Sales, Revenue and Gross Margin (2016-2021) 6.9.4 North China Pharmaceutical Company Amiodarone Product Portfolio 6.9.5 North China Pharmaceutical Company Recent Developments/Updates 6.10 Harbin Pharmaceutical Group 6.10.1 Harbin Pharmaceutical Group Corporation Information 6.10.2 Harbin Pharmaceutical Group Description and Business Overview 6.10.3 Harbin Pharmaceutical Group Amiodarone Sales, Revenue and Gross Margin (2016-2021) 6.10.4 Harbin Pharmaceutical Group Amiodarone Product Portfolio 6.10.5 Harbin Pharmaceutical Group Recent Developments/Updates 7 Amiodarone Manufacturing Cost Analysis 7.1 Amiodarone Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Amiodarone 7.4 Amiodarone Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Amiodarone Distributors List 8.3 Amiodarone Customers 9 Amiodarone Market Dynamics 9.1 Amiodarone Industry Trends 9.2 Amiodarone Growth Drivers 9.3 Amiodarone Market Challenges 9.4 Amiodarone Market Restraints 10 Global Market Forecast 10.1 Amiodarone Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Amiodarone by Type (2022-2027) 10.1.2 Global Forecasted Revenue of Amiodarone by Type (2022-2027) 10.2 Amiodarone Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Amiodarone by Application (2022-2027) 10.2.2 Global Forecasted Revenue of Amiodarone by Application (2022-2027) 10.3 Amiodarone Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Amiodarone by Region (2022-2027) 10.3.2 Global Forecasted Revenue of Amiodarone by Region (2022-2027) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Amiodarone Sales (M Doses) Growth Rate Comparison by Type (2021-2027) Table 2. Global Amiodarone Sales (M Doses) Comparison by Application (2021-2027) Table 3. Global Amiodarone Market Size by Region (US$ Million) (2016 VS 2021 VS 2027) Table 4. Key Manufacturers Amiodarone Covered in This Study Table 5. Global Amiodarone Sales (M Doses) of Key Manufacturers (2016-2021) Table 6. Global Amiodarone Sales Market Share by Manufacturers (2016-2021) Table 7. Global Amiodarone Revenue (US$ Million) by Manufacturers (2016-2021) Table 8. Global Amiodarone Revenue Share by Manufacturers (2016-2021) Table 9. Global Market Amiodarone Average Price (USD/K Doses) of Key Manufacturers (2016-2021) Table 10. Manufacturers Amiodarone Manufacturing Sites and Area Served Table 11. Manufacturers Amiodarone Product Type Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Amiodarone by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Amiodarone as of 2020) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Amiodarone Sales by Region (2016-2021) & (M Doses) Table 16. Global Amiodarone Sales Market Share by Region (2016-2021) Table 17. Global Amiodarone Revenue by Region (2016-2021) & (US$ Million) Table 18. North America Amiodarone Sales by Country (2016-2021) & (M Doses) Table 19. North America Amiodarone Sales Market Share by Country (2016-2021) Table 20. North America Amiodarone Revenue by Country (2016-2021) & (US$ Million) Table 21. North America Amiodarone Revenue Market Share by Country (2016-2021) Table 22. Europe Amiodarone Sales by Country (2016-2021) & (M Doses) Table 23. Europe Amiodarone Sales Market Share by Country (2016-2021) Table 24. Europe Amiodarone Revenue by Country (2016-2021) & (US$ Million) Table 25. Europe Amiodarone Revenue Market Share by Country (2016-2021) Table 26. Asia Pacific Amiodarone Sales by Region (2016-2021) & (M Doses) Table 27. Asia Pacific Amiodarone Sales Market Share by Region (2016-2021) Table 28. Asia Pacific Amiodarone Revenue by Region (2016-2021) & (US$ Million) Table 29. Asia Pacific Amiodarone Revenue Market Share by Region (2016-2021) Table 30. Latin America Amiodarone Sales by Country (2016-2021) & (M Doses) Table 31. Latin America Amiodarone Sales Market Share by Country (2016-2021) Table 32. Latin America Amiodarone Revenue by Country (2016-2021) & (US$ Million) Table 33. Latin America Amiodarone Revenue Market Share by Country (2016-2021) Table 34. Middle East and Africa Amiodarone Sales by Country (2016-2021) & (M Doses) Table 35. Middle East and Africa Amiodarone Sales Market Share by Country (2016-2021) Table 36. Middle East and Africa Amiodarone Revenue by Country (2016-2021) & (US$ Million) Table 37. Middle East and Africa Amiodarone Revenue Market Share by Country (2016-2021) Table 38. Global Amiodarone Sales (M Doses) by Type (2016-2021) Table 39. Global Amiodarone Sales Market Share by Type (2016-2021) Table 40. Global Amiodarone Revenue (Million US$) by Type (2016-2021) Table 41. Global Amiodarone Revenue Share by Type (2016-2021) Table 42. Global Amiodarone Price (USD/K Doses) by Type (2016-2021) Table 43. Global Amiodarone Sales (M Doses) by Application (2016-2021) Table 44. Global Amiodarone Sales Market Share by Application (2016-2021) Table 45. Global Amiodarone Revenue (Million US$) by Application (2016-2021) Table 46. Global Amiodarone Revenue Share by Application (2016-2021) Table 47. Global Amiodarone Price (USD/K Doses) by Application (2016-2021) Table 48. Sanofi Corporation Information Table 49. Sanofi Description and Business Overview Table 50. Sanofi Amiodarone Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2016-2021) Table 51. Sanofi Amiodarone Product Table 52. Sanofi Recent Developments/Updates Table 53. Sawai Pharmaceutical Corporation Information Table 54. Sawai Pharmaceutical Description and Business Overview Table 55. Sawai Pharmaceutical Amiodarone Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2016-2021) Table 56. Sawai Pharmaceutical Amiodarone Product Table 57. Sawai Pharmaceutical Recent Developments/Updates Table 58. Wyeth Pharmaceuticals(Pfizer) Corporation Information Table 59. Wyeth Pharmaceuticals(Pfizer) Description and Business Overview Table 60. Wyeth Pharmaceuticals(Pfizer) Amiodarone Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2016-2021) Table 61. Wyeth Pharmaceuticals(Pfizer) Amiodarone Product Table 62. Wyeth Pharmaceuticals(Pfizer) Recent Developments/Updates Table 63. Mylan Pharmaceuticals Corporation Information Table 64. Mylan Pharmaceuticals Description and Business Overview Table 65. Mylan Pharmaceuticals Amiodarone Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2016-2021) Table 66. Mylan Pharmaceuticals Amiodarone Product Table 67. Mylan Pharmaceuticals Recent Developments/Updates Table 68. Arrow Pharma Pty Ltd Corporation Information Table 69. Arrow Pharma Pty Ltd Description and Business Overview Table 70. Arrow Pharma Pty Ltd Amiodarone Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2016-2021) Table 71. Arrow Pharma Pty Ltd Amiodarone Product Table 72. Arrow Pharma Pty Ltd Recent Developments/Updates Table 73. Roemmers Corporation Information Table 74. Roemmers Description and Business Overview Table 75. Roemmers Amiodarone Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2016-2021) Table 76. Roemmers Amiodarone Product Table 77. Roemmers Recent Developments/Updates Table 78. Cipla Pharmaceutical Corporation Information Table 79. Cipla Pharmaceutical Description and Business Overview Table 80. Cipla Pharmaceutical Amiodarone Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2016-2021) Table 81. Cipla Pharmaceutical Amiodarone Product Table 82. Cipla Pharmaceutical Recent Developments/Updates Table 83. Shanghai Pharmaceuticals Corporation Information Table 84. Shanghai Pharmaceuticals Description and Business Overview Table 85. Shanghai Pharmaceuticals Amiodarone Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2016-2021) Table 86. Shanghai Pharmaceuticals Amiodarone Product Table 87. Shanghai Pharmaceuticals Recent Developments/Updates Table 88. North China Pharmaceutical Company Corporation Information Table 89. North China Pharmaceutical Company Description and Business Overview Table 90. North China Pharmaceutical Company Amiodarone Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2016-2021) Table 91. North China Pharmaceutical Company Amiodarone Product Table 92. North China Pharmaceutical Company Recent Developments/Updates Table 93. Harbin Pharmaceutical Group Corporation Information Table 94. Harbin Pharmaceutical Group Description and Business Overview Table 95. Harbin Pharmaceutical Group Amiodarone Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2016-2021) Table 96. Harbin Pharmaceutical Group Amiodarone Product Table 97. Harbin Pharmaceutical Group Recent Developments/Updates Table 98. Production Base and Market Concentration Rate of Raw Material Table 99. Key Suppliers of Raw Materials Table 100. Amiodarone Distributors List Table 101. Amiodarone Customers List Table 102. Amiodarone Market Trends Table 103. Amiodarone Growth Drivers Table 104. Amiodarone Market Challenges Table 105. Amiodarone Market Restraints Table 106. Global Amiodarone Sales Forecast by Type (2022-2027) & (M Doses) Table 107. Global Amiodarone Sales Market Share Forecast by Type (2022-2027) Table 108. Global Amiodarone Revenue Forecast by Type (2022-2027) & (US$ Million) Table 109. Global Amiodarone Revenue Market Share Forecast by Type (2022-2027) Table 110. Global Amiodarone Sales Forecast by Application (2022-2027) & (M Doses) Table 111. Global Amiodarone Sales Market Share Forecast by Application (2022-2027) Table 112. Global Amiodarone Revenue Forecast by Application (2022-2027) & (US$ Million) Table 113. Global Amiodarone Revenue Market Share Forecast by Application (2022-2027) Table 114. Global Amiodarone Sales Forecast by Region (2022-2027) & (M Doses) Table 115. Global Amiodarone Sales Market Share Forecast by Region (2022-2027) Table 116. Global Amiodarone Revenue Forecast by Region (2022-2027) & (US$ Million) Table 117. Global Amiodarone Revenue Market Share Forecast by Region (2022-2027) Table 118. Research Programs/Design for This Report Table 119. Key Data Information from Secondary Sources Table 120. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Amiodarone Figure 2. Global Amiodarone Market Share by Type in 2020 & 2027 Figure 3. Tablet Amiodarone Product Picture Figure 4. Capsule Amiodarone Product Picture Figure 5. Injection Amiodarone Product Picture Figure 6. Global Amiodarone Market Share by Application in 2020 & 2027 Figure 7. Cardiac Arrest Figure 8. Ventricular Tachycardia Figure 9. Atrial Fibrillation Figure 10. Others Figure 11. Global Amiodarone Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 12. Global Amiodarone Market Size 2016-2027 (US$ Million) Figure 13. Global Amiodarone Sales 2016-2027 (M Doses) Figure 14. Global Amiodarone Market Size Market Share by Region: 2016 VS 20210 VS 2027 Figure 15. Amiodarone Sales Share by Manufacturers in 2020 Figure 16. Global Amiodarone Revenue Share by Manufacturers in 2020 Figure 17. The Global 5 and 10 Largest Amiodarone Players: Market Share by Revenue in 2020 Figure 18. Amiodarone Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021 Figure 19. Global Amiodarone Sales Market Share by Region (2016-2021) Figure 20. Global Amiodarone Sales Market Share by Region in 2020 Figure 21. Global Amiodarone Revenue Market Share by Region (2016-2021) Figure 22. Global Amiodarone Revenue Market Share by Region in 2020 Figure 23. U.S. Amiodarone Revenue Growth Rate (2016-2021) (US$ Million) Figure 24. Canada Amiodarone Revenue Growth Rate (2016-2021) (US$ Million) Figure 25. Germany Amiodarone Revenue Growth Rate (2016-2021) (US$ Million) Figure 26. France Amiodarone Revenue Growth Rate (2016-2021) (US$ Million) Figure 27. U.K. Amiodarone Revenue Growth Rate (2016-2021) (US$ Million) Figure 28. Italy Amiodarone Revenue Growth Rate (2016-2021) (US$ Million) Figure 29. Russia Amiodarone Revenue Growth Rate (2016-2021) (US$ Million) Figure 30. China Amiodarone Revenue Growth Rate (2016-2021) (US$ Million) Figure 31. Japan Amiodarone Revenue Growth Rate (2016-2021) (US$ Million) Figure 32. South Korea Amiodarone Revenue Growth Rate (2016-2021) (US$ Million) Figure 33. India Amiodarone Revenue Growth Rate (2016-2021) (US$ Million) Figure 34. Australia Amiodarone Revenue Growth Rate (2016-2021) (US$ Million) Figure 35. Taiwan Amiodarone Revenue Growth Rate (2016-2021) (US$ Million) Figure 36. Indonesia Amiodarone Revenue Growth Rate (2016-2021) (US$ Million) Figure 37. Thailand Amiodarone Revenue Growth Rate (2016-2021) (US$ Million) Figure 38. Malaysia Amiodarone Revenue Growth Rate (2016-2021) (US$ Million) Figure 39. Philippines Amiodarone Revenue Growth Rate (2016-2021) (US$ Million) Figure 40. Vietnam Amiodarone Revenue Growth Rate (2016-2021) (US$ Million) Figure 41. Mexico Amiodarone Revenue Growth Rate (2016-2021) (US$ Million) Figure 42. Brazil Amiodarone Revenue Growth Rate (2016-2021) (US$ Million) Figure 43. Argentina Amiodarone Revenue Growth Rate (2016-2021) (US$ Million) Figure 44. Turkey Amiodarone Revenue Growth Rate (2016-2021) (US$ Million) Figure 45. Saudi Arabia Amiodarone Revenue Growth Rate (2016-2021) (US$ Million) Figure 46. U.A.E Amiodarone Revenue Growth Rate (2016-2021) (US$ Million) Figure 47. Sales Market Share of Amiodarone by Type (2016-2021) Figure 48. Sales Market Share of Amiodarone by Application (2016-2021) Figure 49. Sales Market Share of Amiodarone by Application in 2020 Figure 50. Revenue Share of Amiodarone by Application (2016-2021) Figure 51. Revenue Share of Amiodarone by Application in 2020 Figure 52. Manufacturing Cost Structure of Amiodarone Figure 53. Manufacturing Process Analysis of Amiodarone Figure 54. Amiodarone Industrial Chain Analysis Figure 55. Channels of Distribution Figure 56. Distributors Profiles Figure 57. Bottom-up and Top-down Approaches for This Report Figure 58. Data Triangulation Figure 59. Key Executives Interviewed

Sanofi Sawai Pharmaceutical Wyeth Pharmaceuticals(Pfizer) Mylan Pharmaceuticals Arrow Pharma Pty Ltd Roemmers Cipla Pharmaceutical Shanghai Pharmaceuticals North China Pharmaceutical Company Harbin Pharmaceutical Group